CClinicalTrials.gg
CompletedNCT05401344Updated Jun 2, 2022

The Objective Assessment and Characteristics of Dry Nose From Clinical Perspective

An observational study in Diagnostic Self Evaluation, sponsored by Beijing Tongren Hospital. Completed at 1 site in China. Open to participants aged 23 Years to 73 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-06-02.

Sponsored by Beijing Tongren Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
120
Ages
23 Years to 73 Years
Sex
All
01

Study summary

In the present study, we propose objective diagnostic criteria for dry nose (DN) and investigate its characteristics. Questionnaires were completed by each participant during recruitment to record demographic data. DN test strips were used to evaluate the severity of DN at five time points and allergic status was assessed based on serum sIgE levels. Nasal secretions were collected and vasomotor rhinitis was diagnosed using the cold dry air test. The diagnosis of allergic rhinitis (AR) was based on the criteria of the Allergic Rhinitis and its Impact on Asthma consensus statement. Data are expressed as median and interquartile range, unless otherwise specified. Statistical significance was set at P \< 0.05. The reference range (RR) of the 5th, 10th, 25th, 50th, 75th, 90th, and 95th percentiles were determined for each test strip length at each time point. This study aimed to investigate the characteristics of and propose objective diagnostic criteria for DN.

02

Conditions studied

  • Diagnostic Self Evaluation
03

In context

Lead sponsor

Beijing Tongren Hospital is the lead sponsor of 154 studies on the registry; 49 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
23 Years to 73 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Overall, 20 patients (13 men and seven women) with dry nose and 100 controls (47 men and 53 women) were recruited for the study. The ages of the participants ranged from 23 to 73 years (mean = 47.7 years).

Inclusion criteria

  • Clinical diagnosis of dry nose patients.

Exclusion criteria

Exclusion Criteria:

  • chronic rhinosinusitis and/or nasal polyposis, allergic fungal rhinosinusitis, immunological disease, tumor patients, pregnant women.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
120 participants (actual)
Patient registry
No

Groups and cohorts

  • dry nose patients

    Diagnostic Test: test strips,sponges and cold dry air test

  • normal controls

    Diagnostic Test: test strips,sponges and cold dry air test

Interventions

  • Diagnostic testtest strips,sponges and cold dry air test

    Test strips were used to evaluated the degree of dry nose, sponges were used to obtain the nasal secretion and cold dry air test was used to making diagnosis of vasomotor rihinitis.

06

What researchers measure

Primary outcomes

  1. The length of the test strip.

    We propose that the diagnostic criterion for DN is a strip length less than 17.0 mm at 5 min.

    Time frame: 5 minutes

07

Study locations

1 site
  • Yifan Meng
    Beijing, Beijing 010, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 2, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05401344
Lead sponsor
Beijing Tongren Hospital
Responsible party
Sponsor
First posted
Jun 2, 2022
Start date
Dec 11, 2018
Primary completion
Jul 24, 2021
Completion
Oct 31, 2021
Last update
Jun 2, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion